1. Prostate Cancer: Highlights from 2006
Pierre Teillac, Pierre Mongiat-Artus 
European Urology Supplements 
Volume 6, Issue 12, Pages (July 2007)
DOI: /j.eursup
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
A significantly higher percentage of men were positive for prostate cancer (PCa) (p<0.001) and had a Gleason score≥7 when PSA ranged between 4 to 10ng/ml compared with PSA<4ng/ml [6].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

3. Fig. 2
Active surveillance results in a low risk of disease progression at 5 yr if patients meet all inclusion criteria (details outlined in the text) [7].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

4. Fig. 3
Partin tables are not able to predict lymph node involvement (LNM) to equal percentages as obtained after biopsies for both Gleason 2–4 and Gleason 5–6 groups [14].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

5. Fig. 4
Patients with positive surgical margins (PSMs) after laparoscopic radical prostatectomy are at increased risk for biochemical recurrence with increasing margin size [17].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

6. Fig. 5
There is no significant difference between radical prostatectomy (RP) and external beam radiation therapy (EBRT) in terms of clinical disease progression, survival rates, and sexual dysfunction [18].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

7. Fig. 6
Interactive voting indicates that radical prostatectomy (RP) and the combination of external beam radiation therapy (EBRT) with luteinising hormone-releasing hormone (LHRH) agonist therapy are the favoured treatment options for the given case (details outlined in the text).
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

8. Fig. 7
Interactive voting shows that radical prostatectomy (RP) and active surveillance are the most chosen treatment options for the given case (details outlined in the text). Luteinising hormone-releasing hormone (LHRH) agonist therapy and high-intensity focused ultrasound (HIFU) were the less favoured options.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions